In an unexpected move last week, the Office of the United States
Trade Representative (on behalf of the Biden-Harris Administration)
announced its support for a waiver of intellectual property
protections afforded by the TRIPS Agreement for Covid-19
vaccines.
The announcement represents a shift in position by the US which
(along with the EU, UK, Japan, Switzerland, Brazil and Norway)
resisted a similar proposal submitted by India and South Africa in
October 2020.
A waiver of patent protection for Covid-19 treatments is
supported by India, South Africa and 57 other World Trade
Organisation Members. Further, both Labour and the Liberal
Democrats have urged the UK government to support a waiver. The UK
is yet to formally announce its position.